Assignee
MEIRAGTX UK II LTD
GB·7 granted patents·10 pending applications·9 citations·filing 2016–2023
Top patents by PatentIndex Score
17 records- 0183US10494646B2Regulation of gene expression by aptamer-mediated modulation of alternative splicingMEIRAGTX UK II LTD·Filed 2016·Granted Dec 3, 2019·6 cites·17 claims
- 0277US11248239B2Regulation of gene expression by aptamer-mediated modulation of alternative splicingMEIRAGTX UK II LTD·Filed 2019·Granted Feb 15, 2022·2 cites·24 claims
- 0373US12359199B2Regulation of gene expression via aptamer-mediated control of self-cleaving ribozymesMEIRAGTX UK II LTD·Filed 2022·Granted Jul 15, 2025·0 cites·25 claims
- 0472US11371077B2High throughput cell-based screening for aptamersMEIRAGTX UK II LTD·Filed 2017·Granted Jun 28, 2022·1 cites·39 claims
- 0571US2024002862A1Regulation of gene expression by aptamer-modulated rnase p cleavageMEIRAGTX UK II LTD·Filed 2023·Application pending·0 cites
- 0663US2023065720A1High Throughput Cell-Based Screening for AptamersMEIRAGTX UK II LTD·Filed 2022·Application pending·0 cites
- 0762US2024279682A1AAV Manufacturing MethodsMEIRAGTX UK II LTD·Filed 2022·Application pending·0 cites
- 0859US2025101436A1Aptamers and small molecule ligandsMEIRAGTX UK II LTD·Filed 2022·Application pending·0 cites
- 0955US11739333B2Regulation of gene expression by aptamer-modulated RNase p cleavageMEIRAGTX UK II LTD·Filed 2018·Granted Aug 29, 2023·0 cites·25 claims
- 1055US11697815B2Regulation of gene expression through aptamer-modulated polyadenylationMEIRAGTX UK II LTD·Filed 2017·Granted Jul 11, 2023·0 cites·30 claims
- 1155US11512310B2Regulation of gene expression via aptamer-mediated control of self-cleaving ribozymesMEIRAGTX UK II LTD·Filed 2017·Granted Nov 29, 2022·0 cites·23 claims
- 1254US2025302992A1Polycistronic Expression of Gut PeptidesMEIRAGTX UK II LTD·Filed 2022·Application pending·0 cites
- 1349US2020010836A1Regulation of Gene Expression by Aptamer-Mediated Accessibility of Polyadenylation SignalsMEIRAGTX UK II LTD·Filed 2018·Application pending·0 cites
- 1448US2024307559A1Kcnv2 gene therapyMEIRAGTX UK II LTD·Filed 2022·Application pending·0 cites
- 1547US2025002936A1RETGC Gene TherapyMEIRAGTX UK II LTD·Filed 2022·Application pending·0 cites
- 1645US2023050187A1Methods for Treating Parkinson's DiseaseMEIRAGTX UK II LTD·Filed 2020·Application pending·0 cites
- 1740US2022267797A1Modified AAV Capsid Proteins for Treatment of Arthritic DiseaseMEIRAGTX UK II LTD·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when MEIRAGTX UK II LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →